US Patent Issued to Pfizer on June 17 for "GLP-1 receptor agonists and uses thereof" (American, Swiss, German Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,041, issued on June 17, was assigned to Pfizer Inc. (New York).

"GLP-1 receptor agonists and uses thereof" was invented by Gary Erik Aspnes (Biberach an der Riss, Germany), Scott W. Bagley (Voluntown, Conn.), Edward L. Conn (Griswold, Conn.), John M. Curto (Mystic, Conn.), David J. Edmonds (Basel, Switzerland), Mark E. Flanagan (Gales Ferry, Conn.), Kentaro Futatsugi (Sharon, Mass.), David A. Griffith (Sudbury, Mass.), Kim Huard (Berkeley, Calif.), Chris Limberakis (Pawcatuck, Conn.), Alan M. Mathiowetz (Waltham, Mass.), David W. Piotrowski (Waterford, Conn.) and Roger B. Ruggeri (Waterford, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provi...